Matches in SemOpenAlex for { <https://semopenalex.org/work/W3177366886> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W3177366886 abstract "Insulin resistance in skeletal muscle contributes to whole body hyperglycaemia in pre-diabetic and type 2 diabetic individuals. Insulin-dependent glucose uptake in skeletal muscle requires the upregulation of the Akt-AS160 signalling cascade (Bruss et al., 2005; Mackenzie & Elliott, 2014). Muscle contraction increases both insulin-stimulated glucose uptake (Kramer et al., 2006) and Akt phosphorylation (Deshmukh et al., 2006) in the hours following exercise. Inositol hexakisphosphate kinase-1 (IP6K1) produces IP7 (Chakraborty et al., 2010), which may inhibit insulin-stimulated glucose transport in muscle by competing with PIP3 at the PH domain of Akt. Currently, there are no data on IP6K1 content in human skeletal muscle. Here we aimed to investigate the effects of two different types of exercise on insulin sensitivity and IP6K1 muscle content in pre-diabetic individuals. This work also used an IP6K1 inhibitor (TNP) to investigate the potential role of IP6K1 in insulin signalling in the C2C12 skeletal muscle cell line. Nine pre-diabetic [47 (3) yr; BMI, 32.0 (2.4); Body Fat, 39.0 (4.4)%; HbA1c 6.1 (0.2)%; fasting blood glucose 6.5 (0.4) mmol/l; HOMAIR 3.7 (0.7)] individuals were recruited to take part in a resting control, a continuous exercise (90% of lactate threshold) and a high-intensity intermittent exercise trial (HIIE; 6 × 30 sec sprints). Muscle biopsies were taken pre- and post each 60-minute trial. A labeled ([6,6-2H2]glucose) intravenous glucose tolerance test (IVGTT) was performed immediately after the second muscle sample. The labelled IVGTT allows for the measurement of two-compartment models of insulin sensitivity (SI2*) and hepatic glucose production (HGP). In an in vitro experiment, C2C12 cells were grown and differentiated under standard conditions before being treated with insulin (100 nM) +/− the IP6K1 inhibitor N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine(TNP) (10μM) for 24 hours. Akt308 phosphorylation was significantly increased following HIIE (P = 0.003), with IP6K1 muscle protein content (P = 0.001) and mRNA expression (P = 0.02) reduced for the same exercise trial. Continuous exercise had no effect on either pAkt308 (P = 0.175) or IP6K1 protein content (P = 0.337). There was no effect on protein IP6K1 content following continuous exercise. HIIE also reduced HGP and improved SI2*. In addition, with HIIE, SI2* was significantly greater in the 4 hours after exercise than with continuous exercise. Chemical inhibition of IP6K1 with TNP in vitro increased p/t Akt308 and p/t AS160642 while decreasing IP6K1 in insulin treated myotubes. This work showed that high-intensity interval exercise reduces muscle IP6K1 in prediabetic individuals, with the same exercise treatment increasing activity of the traditional insulin signaling cascade (Akt-AS160). These data suggest that high-intensity interval exercise is more effective than moderate-intensity continuous exercise at improving glycaemic control acutely in individuals at risk of diabetes. Further, IP6K1 may be linked to reduced muscle responsiveness to insulin. Support or Funding Information This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal." @default.
- W3177366886 created "2021-07-05" @default.
- W3177366886 creator A5008292430 @default.
- W3177366886 creator A5027024402 @default.
- W3177366886 creator A5031012807 @default.
- W3177366886 creator A5037489036 @default.
- W3177366886 creator A5046909418 @default.
- W3177366886 creator A5050736086 @default.
- W3177366886 creator A5070919820 @default.
- W3177366886 creator A5079755287 @default.
- W3177366886 creator A5089431890 @default.
- W3177366886 date "2018-04-01" @default.
- W3177366886 modified "2023-09-23" @default.
- W3177366886 title "High‐intensity Interval Exercise decreases IP6K1 Muscle Content & Improves Insulin Sensitivity (S I 2* ) in Pre‐diabetic Individuals" @default.
- W3177366886 cites W2016391867 @default.
- W3177366886 cites W2017820712 @default.
- W3177366886 cites W2100679082 @default.
- W3177366886 cites W2148321229 @default.
- W3177366886 cites W2150889500 @default.
- W3177366886 doi "https://doi.org/10.1096/fasebj.2018.32.1_supplement.719.7" @default.
- W3177366886 hasPublicationYear "2018" @default.
- W3177366886 type Work @default.
- W3177366886 sameAs 3177366886 @default.
- W3177366886 citedByCount "0" @default.
- W3177366886 crossrefType "journal-article" @default.
- W3177366886 hasAuthorship W3177366886A5008292430 @default.
- W3177366886 hasAuthorship W3177366886A5027024402 @default.
- W3177366886 hasAuthorship W3177366886A5031012807 @default.
- W3177366886 hasAuthorship W3177366886A5037489036 @default.
- W3177366886 hasAuthorship W3177366886A5046909418 @default.
- W3177366886 hasAuthorship W3177366886A5050736086 @default.
- W3177366886 hasAuthorship W3177366886A5070919820 @default.
- W3177366886 hasAuthorship W3177366886A5079755287 @default.
- W3177366886 hasAuthorship W3177366886A5089431890 @default.
- W3177366886 hasConcept C11960822 @default.
- W3177366886 hasConcept C126322002 @default.
- W3177366886 hasConcept C134018914 @default.
- W3177366886 hasConcept C185592680 @default.
- W3177366886 hasConcept C2776050358 @default.
- W3177366886 hasConcept C2777180221 @default.
- W3177366886 hasConcept C2777391703 @default.
- W3177366886 hasConcept C2777866211 @default.
- W3177366886 hasConcept C2779306644 @default.
- W3177366886 hasConcept C2779959927 @default.
- W3177366886 hasConcept C55493867 @default.
- W3177366886 hasConcept C555293320 @default.
- W3177366886 hasConcept C71924100 @default.
- W3177366886 hasConcept C75217442 @default.
- W3177366886 hasConceptScore W3177366886C11960822 @default.
- W3177366886 hasConceptScore W3177366886C126322002 @default.
- W3177366886 hasConceptScore W3177366886C134018914 @default.
- W3177366886 hasConceptScore W3177366886C185592680 @default.
- W3177366886 hasConceptScore W3177366886C2776050358 @default.
- W3177366886 hasConceptScore W3177366886C2777180221 @default.
- W3177366886 hasConceptScore W3177366886C2777391703 @default.
- W3177366886 hasConceptScore W3177366886C2777866211 @default.
- W3177366886 hasConceptScore W3177366886C2779306644 @default.
- W3177366886 hasConceptScore W3177366886C2779959927 @default.
- W3177366886 hasConceptScore W3177366886C55493867 @default.
- W3177366886 hasConceptScore W3177366886C555293320 @default.
- W3177366886 hasConceptScore W3177366886C71924100 @default.
- W3177366886 hasConceptScore W3177366886C75217442 @default.
- W3177366886 hasIssue "S1" @default.
- W3177366886 hasLocation W31773668861 @default.
- W3177366886 hasOpenAccess W3177366886 @default.
- W3177366886 hasPrimaryLocation W31773668861 @default.
- W3177366886 hasRelatedWork W2012273189 @default.
- W3177366886 hasRelatedWork W2026316039 @default.
- W3177366886 hasRelatedWork W2049881486 @default.
- W3177366886 hasRelatedWork W2094672900 @default.
- W3177366886 hasRelatedWork W2096420073 @default.
- W3177366886 hasRelatedWork W2158578106 @default.
- W3177366886 hasRelatedWork W2309978229 @default.
- W3177366886 hasRelatedWork W2352943289 @default.
- W3177366886 hasRelatedWork W2410789767 @default.
- W3177366886 hasRelatedWork W3113810870 @default.
- W3177366886 hasVolume "32" @default.
- W3177366886 isParatext "false" @default.
- W3177366886 isRetracted "false" @default.
- W3177366886 magId "3177366886" @default.
- W3177366886 workType "article" @default.